Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: a solution for an unmet public health need

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1016/j.vaccine.2017.09.055
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleVaccine
ISSN0264-410X
Pages# of pages: 8
SubjectHaemophilus influenzae serotype a; conjugate vaccine; capsular polysaccharide
Abstract
Publication date
PublisherElsevier
LanguageEnglish
In pressYes
Peer reviewedYes
NPARC number23002267
Export citationExport as RIS
Report a correctionReport a correction
Record identifier30f33250-ed59-47de-931e-4efec4ee89f1
Record created2017-09-27
Record modified2017-09-27
Date modified: